Maven Capital Partners
Blacktrace designs, develops and manufactures cutting-edge technologies and products for many applications in chemistry, microfluidics, biology, and nanomaterial sciences. The business has built a reputation for world-class innovation and continuous development of new products and technologies, with its portfolio of products now marketed and sold globally.
Established in 2001, the Blacktrace has grown year on year and now employs a large team of world-class scientists and engineers at its state-of-the-art testing and manufacturing facility near Cambridge. Its customers include all the top 20 pharmaceutical companies, a wide range of major academic institutes, biotechs, start-ups, petrochemical companies, and food manufacturers.